Dosage and administration
- Clean the affected area and dry thoroughly. - Shake bottle well before use. - Spray 4-6 inches from skin twice daily (morning and night) or as directed by a physician. No rub-in is required.
- Clean the affected area and dry thoroughly. - Shake bottle well before use. - Spray 4-6 inches from skin twice daily (morning and night) or as directed by a physician. No rub-in is required.
Miconazole Nitrate 2%
Dimethicone 10%
Petrolatum 10%
Antifungal / Skin Protectant
- Ask a doctor before use on children under the age of two. For external use only.
- When using this product do not get into eyes.
- Stop use and ask a doctor if: irritation develops; there is no improvement within 4 weeks for athlete's foot or ringworm; or within 2 weeks for jock itch.
- Clean the affected area and dry thoroughly.
- Shake bottle well before use.
- Spray 4-6 inches from skin twice daily (morning and night) or as directed by a physician. No rub-in is required.
Cyclomethicone, Hexamethyldisiloxane, Lanolin, Light Mineral Oil, Microcrystalline Wax, Vitamin A Palmitate, Vitamin D3, Water, White Petrolatum
Uses: Treats jock itch, ringworm, and athlete's foot
- Keep out of reach of children. If swallowed, get medical help or contact a local poison control center immediately
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1000009 | miconazole nitrate 2 % / dimethicone 10 % / zinc oxide 10 % Topical Spray | PSN | 2 |
| 1089121 | RASH RELIEF Antifungal 2 % / 10 % / 10 % Topical Spray | PSN | 2 |
| 1089121 | dimethicone 100 MG/ML / miconazole nitrate 20 MG/ML / zinc oxide 100 MG/ML Topical Spray [Rash Relief Antifungal] | SBD | 2 |
| 1000009 | dimethicone 100 MG/ML / miconazole nitrate 20 MG/ML / zinc oxide 100 MG/ML Topical Spray | SCD | 2 |
| 1000009 | dimethicone 10 % / miconazole nitrate 2 % / zinc oxide 10 % Topical Spray | SY | 2 |
| 1000009 | dimethicone 100 MG/ML / Miconazole Nitrate 20 MG/ML / ZNO 100 MG/ML Topical Spray | SY | 2 |
| 1089121 | dimethicone 100 MG/ML / Miconazole Nitrate 20 MG/ML / ZNO 100 MG/ML Topical Spray [Rash Relief Antifungal] | SY | 2 |
| 1089121 | Rash Relief Antifungal (dimethicone 10 % / miconazole nitrate 2 % / zinc oxide 10 % ) Topical Spray | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| MICONAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3a55f4fb-5aec-4c88-0ff7-4d608ad4866a | Product name | 1 | 20140508 |
| 5b9a7965-36d2-8412-dcaf-f76a65411611 | Product name | 1 | 20140508 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 15071-804-11 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b7fe-f6ea-e053-dbdaa90aa703 | RASH RELIEF ANTIFUNGAL SPRAY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15071-804-11 | Rash Relief Antifungal | 56 g in 1 BOTTLE | LIQUID | 56 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Miconazole Nitrate | ACTIVE INGREDIENT | VW4H1CYW1K | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 2 | |
| Miconazole | ACTIVE MOIETY | 7NNO0D7S5M | 2 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 2 | |
| Cholecalciferol | INACTIVE INGREDIENT | 1C6V77QF41 | 2 | |
| Cyclomethicone | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| Hexamethyldisiloxane | INACTIVE INGREDIENT | D7M4659BPU | 2 | |
| Lanolin | INACTIVE INGREDIENT | 7EV65EAW6H | 2 | |
| Microcrystalline Wax | INACTIVE INGREDIENT | XOF597Q3KY | 2 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 15071-804 | 15071-804-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Miconazole Nitrate | VW4H1CYW1K | ACTIB |
| Dimethicone | 92RU3N3Y1O | ACTIB |
| Mineral Oil | T5L8T28FGP | IACT |
| Cyclomethicone | NMQ347994Z | IACT |
| Lanolin | 7EV65EAW6H | IACT |
| Microcrystalline Wax | XOF597Q3KY | IACT |
| Hexamethyldisiloxane | D7M4659BPU | IACT |
| Water | 059QF0KO0R | IACT |
| Cholecalciferol | 1C6V77QF41 | IACT |
| Vitamin A Palmitate | 1D1K0N0VVC | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
| Zinc Oxide | SOI2LOH54Z | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | GEL / TOPICAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | OINTMENT / TOPICAL | 3575 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CREAM / VAGINAL | 23 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Microcrystalline Wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CAPSULE, EXTENDED RELEASE / ORAL | 6 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Lanolin | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Cyclomethicone | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2d4f02ce-0bf1-4f31-9eb8-ee649af17ec2 | 4114c685-acd1-4c65-842b-1cb7840852dc | 2011-11-16 | Warnings | 2d4f02ce-0bf1-4f31-9eb8-ee649af17ec2 4114c685-acd1-4c65-842b-1cb7840852dc |
Adverse event summaries are temporarily unavailable. Other product information remains available.